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Aims: To capture in-depth qualitative evidence regarding attitudes to and
experiences of urodynamic testing among men with lower urinary tract symptoms
(LUTS) at each end of the clinical pathway.
Methods: Semi-structured interview study conducted within the Urodynamics for
Prostate Surgery: Randomized Evaluation of Assessment Methods (UPSTREAM)
trial, which randomizedmen to a care pathway including urodynamics or routine non-
invasive tests from 26 secondary care urology sites across England. Men were
interviewed after assessments but prior to treatment, or after surgery for LUTS. Men
were purposively sampled to include those who had urodynamics and those who did
not, and diversity in demographic characteristics and symptom burden. Interviews
were analyzed using inductive thematic analysis.
Results: Forty-onemen participated (25 pre-treatment, 16 post-surgery), ages 52-89.
The 16menwho had not previously experienced urodynamics said theywould accept
the test in their assessment, but somewere apprehensive or wantedmore information.
The 25 men who had experienced urodynamics all found it acceptable, though some
reported pain, infection, or embarrassment. Embarrassment was minimized by
informing patients what the procedure would be like, and ensuring privacy.
Urodynamics was valued for its perceived diagnostic insight. Information deficits
were reported before, during, and after the test. How andwhen results were explained
and the adequacy of explanations varied.
Conclusions: Urodynamics is acceptable to men with LUTS and generally well-
tolerated. To ensure patients are prepared and informed, good communication before
and during the procedure is essential. Privacy should be prioritized, and test results
discussed promptly and in sufficient detail. Staff require training and guidance in
these areas.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited and is not used for commercial purposes.
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1 | INTRODUCTION
Ninety percent of men aged 50-80 years live with one or more
lower urinary tract symptoms (LUTS), which can negatively
impact quality of life.1 LUTS prevalence and severity
increase with age, and with demographic aging the manage-
ment of LUTS is an increasing priority.
Optimal LUTS treatment depends on identifying causal
mechanisms. Urodynamic testing is well established in
functional urological assessment for men with LUTS, to
determine underlying pathologic lower urinary tract condi-
tions.2 Urodynamics with invasive multichannel cystometry
involves inserting small catheters in the bladder and rectum to
measure bladder function and capacity. In current pathways,
multi-channel urodynamics is formenwho remain bothered by
voiding LUTS despite initial pharmacological treatment, and
are therefore considering interventional care.3 It aims to help
determine whether an individual would realistically benefit
from relief of bladder outlet obstruction (BOO) and whether
there are any risk factors for adverse outcomes.
However, there is variation in urodynamic practice in
most countries, including the UK,4 reflecting ongoing debate
about the extent to which urodynamics should be used.3 Some
clinicians advocate routine use of urodynamics to determine
whichmen have BOO andwill therefore benefit from surgery,
and to prevent intervention in men who do not have BOO and
will be at risk of adverse effects of unnecessary surgery (eg,
retrograde ejaculation because of transurethral resection of
the prostate). Others advocate restricted use of urodynamics
due to possible complication rates, perceived unpleasant
experience, lack of evidence of better outcomes, and
associated cost.5,6 Systematic reviews examining the out-
comes of urodynamics are inconclusive,7,8 and current
guidelines consequently make only limited recommendations
for testing.9
The need for an evidence-based understanding of
urodynamics is recognized by the UK National Institute of
Health Research (NIHR), which funded the Urodynamics for
Prostate Surgery: Randomized Evaluation of Assessment
Methods (UPSTREAM) randomized controlled trial.10 By
randomizing 820 men in 26 UK hospitals to either
urodynamic tests with invasive multichannel cystometry or
a care pathway based on non-invasive routine tests,
UPSTREAM aims to determine the effect of urodynamics
on symptoms and rates of BOO surgery in men with
bothersome LUTS seeking further treatment.10 Central to
this, qualitative evidence regarding the acceptability and
tolerance of urodynamics is critical to inform the implemen-
tation of trial findings (to be reported late 2018) and use of
urodynamics in practice.
Existing evidence regarding the acceptability of urody-
namics is largely from questionnaire-based studies and
suggests that urodynamics is well-tolerated,11,12 but can
also be uncomfortable13 and might cause complications,5
though the extent of these is unclear.14 A survey by Scarpero
et al15 found that urodynamics was associated withminimal to
moderate levels of discomfort, anxiety, and embarrassment;
the authors concluded that a suspected lack of tolerance of
urodynamics should not be a barrier to conducting the test.
Other quantitative studies suggest that the pain experienced
during urodynamics is higher in men16 and younger
patients.17 However, there is very little in-depth qualitative
research exploring the experiences and views of men
receiving urodynamics. In 2000, Shaw et al18 published a
qualitative study exploring satisfaction with urodynamics
among 17 female and 4 male patients. They found patients
were anxious because of fear of the unknown, and were
embarrassed at the intimate nature of the procedure and lack
of privacy. However, this study was not designed to explore
the experiences of men in detail, who are likely to have
different experiences of and attitudes towards urodynamics
than women.16
In a large qualitative study nested within the UPSTREAM
trial, we explored men's attitudes to and experiences of
urodynamics, to provide in-depth qualitative evidence to
inform clinical practice.
2 | MATERIALS AND METHODS
2.1 | Study design
In-depth semi-structured interviews were conducted with
patients enrolled in the UPSTREAM trial,10 at 26 secondary
care urology sites across England. The value of combining
qualitative and controlled trial methods has long been
recognized and recommended.19 Qualitative methods are
the most appropriate means to understand trial participants’
experiences of key medical events and trial conduct,20 and we
adhere to international guidelines in study conduct and
reporting.21
Trial inclusion criteria were: men with bothersome LUTS
seeking further treatment for their symptoms, which may
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include surgery. Exclusion criteria included inability to pass
urine without a catheter; relevant neurological disease;
undergoing active treatment, or on active surveillance, for
prostate or bladder cancer; previous prostate surgery; not
medically fit for surgery; or unable to complete outcome
assessments.10
2.2 | Sampling and recruitment
Purposive sampling captured a maximum variation sample in
terms of trial arm, trial site, and socio-demographic and
clinical variables: age, ethnicity, socio-economic status, and
baseline total International Prostate Symptom Score (IPSS).22
Socio-economic status was estimated using the Index of
multiple deprivation decile,23 which ranks areas in England
from most deprived (score of 1) to least deprived (score of
10); we sampled across three categories (high 1-4, medium 5-
7, low 8-10). The IPSS assesses seven symptoms, scored 0
(best)—5 (worst): incomplete emptying, frequency, intermit-
tency, urgency, weak stream, straining, and nocturia. Total
IPSS score at baseline was categorized as high or low using
the American Urological Association (AUA) Symptom Index
classification: ≥20 = high symptom burden (severe symp-
toms) and ≤19 = low symptom burden (mild or moderate
symptoms).22
Patients were recruited for interview at two time-points:
either 1-8 weeks after the consultation in which their
treatment had been decided and recorded, or 6 weeks to
4 months after receiving surgery for LUTS. This was to
capture variation along the treatment pathway and in
treatment types (surgery vs non-invasive treatment) to
investigate if these factors impacted on perceptions of
urodynamics. Informed consent (written for face-to-face
interviews, verbal for phone interviews) was granted by all
participants prior to interview. Patients participating in the
interviews did not receive any incentives.
2.3 | Data collection
Interviews were conducted face-to-face or by telephone by
CAO or LES, both experienced and trained qualitative
researchers with a background in health services research.
Neither researcher works clinically in urology, nor was
previously known to participants, facilitating open, and
candid communication. Topic guides (Box 1) for the
interviews were developed by the research team (both the
clinical and the patient-involvement investigators) based on
the study aims and the literature. Each topic guide was piloted
with two men with LUTS (data not included in analysis) and
refined prior to use. Topic guides were modified as necessary
throughout the course of the study to ensure that issues
emerging from the analysis were explored in future inter-
views. Interviews were digitally audio-recorded and tran-
scribed verbatim prior to analysis. The interviews lasted
between 29 min to 1 h 42 min, mean 50 min.
Box 1 Summary of interview topic guide
Background
 Age, family situation, accommodation and work
circumstances, general health
Lower Urinary Tract Symptoms (LUTS) experience
 Help-seeking triggers for LUTS
 Symptoms experienced, bother and impact, pri-
mary concerns
 Understanding and management of symptoms
 Information received and needed in relation to
LUTS
LUTS assessment/consultation/treatments
 Patient pathway to hospital x, referral process
 Experiences at the hospital
 Assessments and tests received for LUTS includ-
ing urodynamic testing: experiences, understand-
ing of the assessments’ purpose, expectations of
assessments, and information/support
 Explanation of assessment results: format, ade-
quacy, understanding the results
Decision-making
 Treatment decision making process and outcome
 Patient and clinician involvement and role in
decision-making
 Patient preferences re-treatment
 Impact of assessments on treatment decision-
making
 Views of surgery for LUTS
UPSTREAM
 Motivations for taking part in UPSTREAM,
experiences of trial participation
 Understanding of randomization and equipoise,
preferences re-trial arm allocation
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2.4 | Analysis
Data were analyzed using an inductive thematic approach.24
Analysis was conducted in parallel to data collection, with
findings from early analysis informing later data collection
in an iterative process, until analysis indicated data
saturation—such that no new themes were emerging from
the data analysis by the end of data collection. The
researchers (CAO for pre-treatment interviews, LES for
post-surgery interviews) used line-by-line coding to
construct draft coding frames, each based on three
transcripts. A combination of deductive coding, based on
the aims of the study and the topic guide, and inductive
coding, identifying themes within the data, was used. To
enhance analysis, team members (LES, JH, and CAO)
independently coded transcripts to achieve coding consen-
sus and maximize rigor. CAO/LES then applied the refined
coding frame to all the transcripts, with regular meetings
with JH to discuss emerging findings. Finally, LES used
charting to identify patterns in the data and drafted a
narrative based on the analysis, with input from CAO and
JH. Transcripts from the pre-treatment and post-surgery
interviews were analyzed separately and findings then
compared. Data were analyzed using NVivo V10 (QSR
International Pty Ltd., 2012) and Excel. Data extracts are
tagged with a unique participant ID: the prefix “PT” denotes
patients interviewed after their treatment decision but prior
to any planned surgery; “PS” denotes patients interviewed
post-surgery.
3 | RESULTS
Forty-one male patients from diverse locations in England
were interviewed (25 pre-treatment, 16 post-surgery), age
range 52-89 (Table 1). Fifteen patients had a high symptom
burden at baseline. Twenty-five had experienced urodynamic
testing. Four themes were identified: acceptability of
urodynamics, experience of urodynamics, perceived value
of urodynamics, and information deficits.
3.1 | Acceptability of urodynamics
All of the 25menwho underwent urodynamic testing reported
that it was acceptable, despite any discomfort or other issues
they might have experienced. Of the 16 men who had not had
urodynamics previously, 10 said they would have been happy
to have it if needed:
I’m used to being prodded and god knows what
else. I don’t take any notice of that. . . The more
tests the better I always say. . . you know exactly
what's going on then. MrPS5, age 60
Of the remaining six, four said they would have had it if
needed, but would have been apprehensive due to its invasive
nature and were glad it had not been required. Two men said
they would want more information about the test and its
purpose. One man had declined to have urodynamics because
a prior cystoscopy had found a narrow constriction and he did
not want to risk any damage which might delay his planned
surgery.
The main reason for wanting urodynamics was the
perceived accuracy of the test and the desire to have
maximum information to inform the treatment decision:
I like answers. . . and we got the answers. So if I
hadn’t had the test done, then we’re just left with
a load of symptoms which could be caused by
this or that. Erm, so I mean in terms of erm the
invasion of the test, it's. . . not a problem. . .
totally acceptable. MrPT20, age 69
We did not find any evidence of associations between
age or symptom severity and the acceptability of
urodynamics.
3.2 | Experience of urodynamics
3.2.1 | Pain, discomfort, and infection
In general, urodynamics was well-tolerated by the 25
participants who had experienced it. However, there was
variation in how uncomfortable men found the procedure.
Seven reported that it was at least a little painful, with some
experiencing severe pain, but they nevertheless thought
urodynamics was acceptable:
MrPT6 (age 57): Having a tube stuck inside me
and afterwards was 10 out of 10 pain. . . It was
awful. But the people I dealt with were very
good.
Interviewer: Okay, and how acceptable was the
test for you?
MrPT6: Yes, no problem. Obviously embarrass-
ing, uncomfortable, not very pleasant. Erm—
well, I mean, I had the choice of having the test
done or not, so, you know, I read about it, it
sounded horrible, but, erm—I am quite a
positive person. I want to live the best. I’ve
got a family to look after, so. . .
Five men reported that the procedure was pain-free:
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I was quite surprised, actually. Especially at the,
at the rear end, I thought, “Oh, there might be a
pain involved here.” But there wasn’t. I had no
pain at all. I just—it was, it was better than what
I thought it was going to be. MrPT11, age 75
Urodynamics was sometimes perceived as easier and less
uncomfortable than uroflowmetry, because urodynamics
does not involve having to wait with a full bladder:
When they put liquids into you, [it] was more
uncomfortable. . . easier. . . It's able to fill your
bladder through your penis, so that they can
measure the flow. . . That was a bit embarrass-
ing, but like I said, I found it better because I
didn’t have to retain anything. So to me. . .
although embarrassing, [urodynamics] is a
better system [than flowmetry]. MrPT4, age 67
Eight participants reported short-lived negative after-
effects of urodynamics: stinging when urinating, a small
amount of bleeding, a urinary tract infection (UTI) or
disrupted flow/urgency. However, despite these issues the
men said they would willingly have the test again if
needed.
3.3 | Embarrassment
A minority of participants (7/25) reported that having
urodynamics was embarrassing, either due to its intimate
nature or not being prepared for its effects:
The final pee that I was having was with a
catheter up my urethra. Now, how you’re
supposed to pee into a jug when you’ve got a
catheter up you, I do not know. But it went all
over the wall and the floor, er, which embar-
rassed me. If they’d said, “Look, this is what's
going to happen, don’t worry about it”. . .One of
the nurses had to clean it all up when she came
back in. MrPT10, age 63
One patient reported that he found urodynamics less
embarrassing than a rectal exam (“it's not very nice for them
anyway, and certainly not nice for you either” MrPT4).
The degree to which urodynamic assessments (and other
tests for LUTS) were perceived as embarrassing depended in
part on the level of privacy available, including the number of
people in the room during the test, room location and size (a
larger room near a corridor was more socially awkward).
Patients preferred as few people present in the examination
room as possible during the test, that staff were introduced to
them, and they knew their roles:
TABLE 1 Participant characteristics
Pre-treatment
patients
(n= 25)
Post-surgery
patients
(n= 16)
Age group
51-55 1 1
56-60 1 3
61-65 7 2
66-70 7 3
71-75 6 2
76-80 2 3
81-85 1 0
86-90 0 2
Urodynamics received
Yes 17 8
No 8 8
Treatment decision
Conservative 13 N/A
Surgery 12 16
Time since surgery (days)
Median N/A 91.5
Range 48-463
Geographical region (England)
South West 8 6
South East 6 4
London 1 2
East of England 3 1
East Midlands 0 1
West Midlands 2 0
Yorkshire and the Humber 0 1
North West 3 0
North East 1 1
Deprivation decile23
High (1-4) 11 4
Medium (5-7) 9 9
Low (8-10) 5 3
IPSS symptom burden (baseline)22
High (≥20) 8 7
Low (≤19) 17 9
Ethnicity (self-reported)
White British 23 12
Asian/British Asian 1 1
White American 0 1
Iranian 0 1
Afro-Caribbean 0 1
Not given 1 0
IPSS = International prostate symptom score.
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MrPS11 (age 59): It was all right. Embarrassing
[laughs]! Stood there in front of all the people!...
There were a couple of students! [Laughs] A
couple of nurses! [Laughs]
Interviewer: Were you asked about whether you
minded them being there, or...?
Mr PS11: Yeah, yeah, [the doctor] asked me if I
minded if they’d be there. . . I didn’t mind. Yeah, a
little bit embarrassing, but I didn’t mind toomuch.
Another man reported a nurse coming in without
knocking during the procedure and being reprimanded by a
more senior nurse.
Who performed the urodynamic test could also be a
concern and a cause of embarrassment. Two men mentioned
the gender of the person performing the test in relation to their
embarrassment. One would have preferred a woman to have
carried out the test:
MrPT4, age 67: Well, it's not very nice for
another man to play with your. . . Well, not play
with you but actually touch you, they’re doing
things. Then to stand in front of women as
well. . .
Interviewer: Oh, there were women in the room?
MrPT4: Yeah, well, I was asked about. . . One
was a trainee nurse and one was a senior nurse.
So to be quite honest, to me, it's easier for me to
be naked in front of a woman than what it is a
man.
Another said that his test had been performed by a female
nurse and initially he thought he would have preferred a man.
However, by the end of the test he thought it was better to have
it performed by a woman. Despite any embarrassment, men
still found urodynamics acceptable.
3.4 | Perceived value of urodynamics
As previous results suggest, urodynamics was primarily
valued by participants for the additional insight it gave them
and their clinicians into their LUTS:
I was glad that it was clear result in itself. . . it
was effective in actually showing, illustrating
the problem and the extent of the problem. . .it
was effective in actually getting something
sorted. MrPT22, age 64
Urodynamics was often the last in a series of assessments
participants had received for their LUTS. Many patients felt
that having urodynamics meant they had received all the
investigative tests available and therefore had all possible
facts regarding their condition. There was satisfaction in this:
You’re having a test that was different fromwhat
erm, you’d experienced before . . . there was a
sort of finality about that, you know. You felt
that, you know, okay (−) there's nowhere else to
go, you know. MrPT1, age 67
Three patients reported that they found invasive urody-
namic testing interesting or engaging as they learnt about the
cause of their LUTS. Urodynamics was perceived as more
informative than other tests, providing a more accurate
account of the cause of LUTS:
I done the flow rate thing, the urodynamics was I
think far more accurate. . . I thought it was a
very clever test. . . You know, I think it showed a
lot more. . . that other test was probably one of
my bad days, because the growth of a prostate
outside the bladder acts like a ball-valve so it
shuts my flow off. . . Yeah, I think it was a good
test. Mr PT15, 52
For some patients, the results of urodynamics played an
important role in their treatment-decision-making:
Interviewer: Do you think the results of the
assessments that you did helped make the
decision for which treatment you’d get?
MrPT16 (age 68): Oh, yes, yes, yes. . . For both
[clinician and patient], I think, because, I mean,
although they weren’t pleasant, you feel as
though at least everybody's had a go, and
they’ve done as much as they can. And I think
when [consultant] sort of turned round and sort
of said, “Well, that confirms everything”. . . and
he's not made any secrets of what he thought, so
you knew what he was talking about.
3.5 | Information provision
Although overall men's experiences of care were positive,
there were instances along the diagnostic pathway when
participants reported they had been inadequately informed.
Four patients felt that they had not been fully informed about
the process of urodynamics in advance, such as what it would
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involve, the need to urinate and possibly spray, or the risk of
developing a UTI afterwards:
They put a catheter in, and I told them, the nurse
who was doing it. . . “When you put that catheter
in,” I said,“I know for a fact, by at least tomorrow,
I’m going to have an infection.”—“No, every-
thing's sterilized. You won’t have an infection.”
True enough, I had an infection, and it was a
Saturday the next day. My doctor was closed.
MrPT11, age 75
While most participants reported being given leaflets
about the test prior to having it, one patient did not know he
was having urodynamics until he arrived at the hospital on the
day of the test. One participant described the importance of
patients feeling fully informed while awaiting their tests:
Very clear information is very important. You’ll
be sitting here; you’ll be sitting here for an hour.
It’ll be that length of time before we will call you,
or this will take, given the number of people
we’ve got, I expect it’ll be this. If it's wrong, it's
wrong, it doesn’t matter, but actually giving
clear and confident messages allows people to
feel that they’re not completely out of control. . .
they haven’t been forgotten in the corner.
MrPT22, age 64
There was variability in participants’ reports of how and
when their test results were explained to them and the
adequacies of the explanations they received. Men had the
results of urodynamics explained to them during the test by
the technician or nurse undertaking it, from a doctor straight
after receiving the test, or at a separate appointment with a
doctor a short time later. When test results were available and
discussed with a clinician immediately after the test this was
appreciated:
I had an instant diagnosis, saying that I needed
an operation. . . I weren’t expecting that. I was
expecting to have a letter a week later saying,
“We think this, that and the other.”MrPT4, age
67
[Getting] the information on the day, obviously
that's better for everybody, you know. I think it
takes the angst out of it really. MrPT1, age 66
Most men were satisfied with the explanation of test
results, reporting that the explanations received were
excellent or adequate:
So I could understand, you know, what results
they were looking for and they actually showed
me the graph results. So erm, that was quite
interesting. That was explained. MrPT13, age 75
Interviewer: Having done the different tests,
how were the results explained to you?
MrPT6 (age 57): Yes, very well. . . The nurse
explained it to me as well, and then I came back
to the doctor and he went through it with me.
Two men reported poor explanations of urodynamics
results. One reported particular problemswith the results of the
urodynamics being explained rapidly straight after the test:
The consultantwas in a hurry, sohe started trying
to explain the readings off the test on the
computer to me while I was still standing there
in a gown with a catheter in. And I said, “I’m
sorry. I can’t take this in now. Can you wait until
I’ve got dressed?” . . . The only thing he [doctor]
said tomewas this thing about,“There's anawful
lot of pressure going in, and not a lot of urine
coming out.” Erm, so I saw, you know, the
computer monitor and one or two printouts, but I
didn’t ask. I wasn’t shown those.MrPT10, age 63
4 | DISCUSSION
This is the first in-depth study of men's attitudes to and
experiences of invasive urodynamic testing for LUTS using
formal qualitative research methodology. We found that
urodynamics testing was acceptable, despite a minority of
participants experiencing pain, UTI, or embarrassment.
Urodynamics was valued for its perceived accuracy and the
information it provided about symptom aetiology, and
thought to give more insight into LUTS than other tests.
Reflecting clinical guidelines,9 urodynamics was carried out
after other assessments such as uroflowmetry and completion
of bladder diaries, and was therefore perceived as completing
the possible assessments comprehensively. For somemen, the
results of urodynamics played an important role in treatment-
decision-making; this will be explored further from clinician
and patient perspectives in a separate publication.
Levels of discomfort and embarrassment experienced
during the test varied, but all the men were prepared to have
the test again if needed, despite any negative experiences.
Embarrassment related to the intimate nature of the test and a
lack of awareness or preparation for its effects. Key to
minimizing embarrassment were good communication and
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privacy: ensuring men knew what to expect, limiting the staff
present, introducing staff, and explaining their role. For some
men, the gender of the person performing the test was
important, with a female clinician preferred. Information
deficits were reported before, during, and after the test, and
there was variability in how and when results were explained
and the adequacy of explanations.
Our findings support those of Scarpero et al,15 who found
that urodynamics was well-tolerated, with patients experienc-
ing minimal to moderate discomfort and embarrassment. As
in Shaw et al's18 mixed-sex (female-predominant) qualitative
study, embarrassment was related to the intimacy of the
procedure and privacy was therefore important. Previous
research has suggested that urodynamics might be less
acceptable to younger patients.17 This was not evidenced
among our participants, but this could be due to the older age
group of men with LUTS, reflected in our study sample (age
range 52-89); Yiou et al17 found being <54 years’ old was
associated with painful sensation in a cohort of 68 men and
103 women.
Strengths of the current study include our focus on an in-
depth understanding of men's perspectives and experiences,
the recruitment of a large and diverse sample in terms of age,
symptom burden, and treatment decision, and the attainment
of data saturation. Not all the men we included had
urodynamic testing, as the views and attitudes of those who
have not had the test are also important in considering
acceptability in the target population. Although for the post-
surgery participants several months had passed since they had
urodynamic testing, participants were able to talk at length
about the procedure, demonstrating that this was a key
medical event for them. The inclusion of these accounts adds
value in capturing the long-lasting perceptions and attitudes to
the procedure and understanding how urodynamic testing is
viewed in relation to the eventual outcome of the treatment
decision and surgery. Analysis demonstrated a high degree of
similarity between pre-treatment and post-surgery interviews,
with both containing positive and negative views and
experiences of urodynamic testing not dependent on
treatment decisions or surgery outcome. Although we
achieved representation across England, more men from
south England were interviewed. Practice, staff expertise, and
patient perspectives might vary in other settings, so specific
aspects of the current findings may vary elsewhere. Finally,
men in this qualitative study had consented to a trial in which
there was a 50% chance of randomization to receive
urodynamics, so those totally opposed to it might not have
consented to the trial; this should be taken into account in
interpreting our findings.
This study has clear clinical implications. It is essential
that clinicians inform patients in advance about what to expect
during and after the test, including the risk and treatment of
UTIs. Patients should be informed that passing urine during
the test can be associated with spraying, and that this will
easily be dealt with afterwards. During urodynamic practice,
efforts should be made to limit the number of staff present in
the assessment room and ensure maximum possible privacy is
maintained. Patients should be introduced to the clinicians
present and informed of their role, with agreement sought for
the involvement of trainees in the procedure. After the test,
patients should be allowed to get dressed in their normal
clothes before the concluding discussions. Clinicians should
discuss side-effects with patients and what to do if they
experience any problems. Clinicians and patients will ideally
discuss the results of urodynamic testing on the same day as
the test or shortly after, with the detail and depth of the
explanation in line with patients’ preference.
Our finding of variability in the degree of privacy,
dignity, discomfort, and information provision experienced
by patients undergoing urodynamic testing indicate that
staff require training and guidance in these areas. Current
urodynamic guidelines9 omit guidance on how to ensure
urological assessment is patient-centered, yet this is crucial
to ensure positive experiences among patients. Inadequacies
in UK training in the conduct of urodynamic investigations
have been reported previously25; our findings suggest that
such training needs to include the sensitive conduct of
invasive urodynamic testing and associated information
provision.
Further research is needed to determine best practice in
the content and timing of information: previous research has
found that information given prior to urodynamics can
increase expectations of pain26 and there have been mixed
results regarding its effect on patient anxiety.27,28
5 | CONCLUSIONS
Our findings suggest that, in the opinion of patients who have
experienced urodynamic testing, the perceived accuracy of
urodynamic findings and the benefits of deriving maximal
clinical information over-ride short-term negative after-
effects. To ensure patients are prepared and informed, good
communication before and during urodynamics is essential.
Privacy should be prioritized, and test results discussed
promptly once the patient is dressed in his normal clothes.
Variability in patients’ experiences suggest that staff require
training and guidance in these areas.
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